Nasdaq bcrx

This website uses cookies so that we can provide you with the best user nasdaq bcrx possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful, nasdaq bcrx. See our Cookie Policy for more information. These cookies are used to deliver our website and content.

BioCryst Pharmaceuticals, Inc. About the company. It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases. Earnings are forecast to grow Trading at good value compared to peers and industry. Negative shareholders equity.

Nasdaq bcrx

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 2. Amarin Corporation plc. AMRN 1. TG Therapeutics Inc common stock. TGTX 1. Aurinia Pharmaceuticals Inc. AUPH 1. Arrowhead Pharmaceuticals Inc. ARWR 3. Novavax Inc. NVAX 1. Iovance Biotherapeutics Inc.

All topics Full year earnings: EPS and revenues miss analyst expectations Feb

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 5. Amarin Corporation plc. AMRN 2. TG Therapeutics Inc common stock.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades.

Profitec 300

Spectral AI technology to revolutionise triage and treatment 07 Mar. UK and active funds sees record outflows as trackers and money markets boom 07 Mar. EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Group VAT registration number Provides Earnings Guidance for the Year Nov Is BCRX overvalued? Future Growth. Earnings per share. Full year earnings: EPS misses analyst expectations Feb Amarin Corporation plc. The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks.

.

Keep track of upcoming events with our Earnings Calendar. Revenue The total amount of income generated by the sale of goods or services related to the company's primary operations. The price came from below 7. Price Volatility. One year price forecast for BioCryst Pharmaceuticals, Inc. Analyst rating. All topics EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. On Off. Neutral Sell Buy. ARWR 3. Group VAT registration number It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases. Montgomery in and is headquartered in Durham, NC. Free cash flow.